Highlights
- Total portfolio value is at all-time high, 56 MEUR.
- Total turnover of all portfolio companies exceeds 14 MEUR.
- Denator gets 0.6 MEUR in investments 2 months after leaving the pre-incubator.
- 5 MEUR in total venture capital investments, among others Oxeon (0.9 MEUR) and Vasasensor (0.6 MEUR).
- Exit in Vehco which was the last portfolio company from the profitable year of 2001.
- The first year of running GIBBS turned out with continuation of all four projects.
- GIBBS appeared in Nature Biotechnology Magazine.
- Awardwinning companies in Venture Cup, Denator (1st place) and Arterion (3rd place).